Resectable, Non-functioning Pituitary Adenoma
1 clinical trials · Condition
◉ Watch Resectable, Non-functioning Pituitary Adenoma
| Record | Firm | Date |
|---|---|---|
| Exploratory Study of Farletuzumab to Treat Resectable, Non-functioning Pituitary Adenomas (NCT01203618) | Morphotek | 2011-02-01 |
Track Resectable, Non-functioning Pituitary Adenoma automatically
Every clearance here is in the API, with alerts when new ones post.